These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 30584072)
1. Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis. Yang F; Takagaki Y; Yoshitomi Y; Ikeda T; Li J; Kitada M; Kumagai A; Kawakita E; Shi S; Kanasaki K; Koya D Cancer Res; 2019 Feb; 79(4):735-746. PubMed ID: 30584072 [TBL] [Abstract][Full Text] [Related]
2. Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells. Li S; Fan Y; Kumagai A; Kawakita E; Kitada M; Kanasaki K; Koya D Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991851 [TBL] [Abstract][Full Text] [Related]
3. Metformin Mitigates DPP-4 Inhibitor-Induced Breast Cancer Metastasis via Suppression of mTOR Signaling. Kawakita E; Yang F; Kumagai A; Takagaki Y; Kitada M; Yoshitomi Y; Ikeda T; Nakamura Y; Ishigaki Y; Kanasaki K; Koya D Mol Cancer Res; 2021 Jan; 19(1):61-73. PubMed ID: 32994182 [TBL] [Abstract][Full Text] [Related]
4. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer. Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564 [TBL] [Abstract][Full Text] [Related]
5. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer. Zhu WB; Zhao ZF; Zhou X J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000 [TBL] [Abstract][Full Text] [Related]
6. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages. Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X Cancer Lett; 2020 Apr; 474():36-52. PubMed ID: 31931030 [TBL] [Abstract][Full Text] [Related]
7. Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis. Mukherjee D; Lu H; Yu L; He C; Lahiri SK; Li T; Zhao J Oncotarget; 2016 Apr; 7(17):23552-68. PubMed ID: 26993780 [TBL] [Abstract][Full Text] [Related]
8. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer. Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Dipeptidyl Peptidase-4 Activates Autophagy to Promote Survival of Breast Cancer Cells via the mTOR/HIF-1α Pathway. Kawakita E; Yang F; Shi S; Takagaki Y; Koya D; Kanasaki K Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760498 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells. Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890 [TBL] [Abstract][Full Text] [Related]
12. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR. Circelli L; Sciammarella C; Guadagno E; Tafuto S; del Basso de Caro M; Botti G; Pezzullo L; Aria M; Ramundo V; Tatangelo F; Losito NS; Ieranò C; D'Alterio C; Izzo F; Ciliberto G; Colao A; Faggiano A; Scala S Oncotarget; 2016 Apr; 7(14):18865-75. PubMed ID: 26934559 [TBL] [Abstract][Full Text] [Related]
13. LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung. Zhang J; Chen J; Wo D; Yan H; Liu P; Ma E; Li L; Zheng L; Chen D; Yu Z; Liang C; Peng J; Ren DN; Zhu W Clin Cancer Res; 2019 Aug; 25(15):4832-4845. PubMed ID: 31010839 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of 3,3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer. Lee GA; Hwang KA; Choi KC Food Chem Toxicol; 2017 Nov; 109(Pt 1):284-295. PubMed ID: 28844962 [TBL] [Abstract][Full Text] [Related]
15. Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis. Aversa I; Zolea F; Ieranò C; Bulotta S; Trotta AM; Faniello MC; De Marco C; Malanga D; Biamonte F; Viglietto G; Cuda G; Scala S; Costanzo F J Exp Clin Cancer Res; 2017 Aug; 36(1):104. PubMed ID: 28774348 [TBL] [Abstract][Full Text] [Related]
16. CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells. Ieranò C; Santagata S; Napolitano M; Guardia F; Grimaldi A; Antignani E; Botti G; Consales C; Riccio A; Nanayakkara M; Barone MV; Caraglia M; Scala S Cell Death Dis; 2014 Jul; 5(7):e1310. PubMed ID: 24991762 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10. Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis. Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662 [TBL] [Abstract][Full Text] [Related]
19. Role of the CXCR4/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma. Clements D; Markwick LJ; Puri N; Johnson SR J Immunol; 2010 Aug; 185(3):1812-21. PubMed ID: 20585037 [TBL] [Abstract][Full Text] [Related]
20. CXCR4-Targeted and Redox Responsive Dextrin Nanogel for Metastatic Breast Cancer Therapy. Zhang F; Gong S; Wu J; Li H; Oupicky D; Sun M Biomacromolecules; 2017 Jun; 18(6):1793-1802. PubMed ID: 28445650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]